Role of TNFR1 in lung injury and altered lung function induced by the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide

Toxicology and Applied Pharmacology

Volumn 250, Issue 3, 2011, Pages 245-255

  Sunil, Vasanthi R ^a   Patel Vayas, Kinal ^a   Shen, Jianliang ^a   Gow, Andrew J ^a   Laskin, Jeffrey D ^b   Laskin, Debra L ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

CEES; COX 2; INOS; Lung function; MCP 1; SOD; TNF ; TNFR1

Indexed keywords

ANTIOXIDANT; CYCLOOXYGENASE 2; ETHYL 2 CHLOROETHYL SULFIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; METHACHOLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P55; SULFIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRASSICA; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; INFLAMMATION; LAVAGE; LUNG FUNCTION; LUNG INJURY; LUNG PARENCHYMA; LUNG RESISTANCE; LUNG TOXICITY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; IRRITANTS; LUNG; LUNG INJURY; MALE; MICE; MICE, KNOCKOUT; MUSTARD GAS; OXIDATIVE STRESS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MUS;

EID: 78651417651     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.10.027     Document Type: Article

References (62)

1. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 2003, 3:745-756.
2. Babin M.C., Ricketts K., Skvorak J.P., Gazaway M., Mitcheltree L.W., Casillas R.P. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J. Appl. Toxicol. 2000, 20(Suppl 1):S141-S144.
3. Bates J.H., Lauzon A.M. Parenchymal tethering, airway wall stiffness, and the dynamics of bronchoconstriction. J. Appl. Physiol. 2007, 102:1912-1920.
4. Bhalla D.K. Ozone-induced lung inflammation and mucosal barrier disruption: toxicology, mechanisms, and implications. J. Toxicol. Environ. Health B Crit. Rev. 1999, 2:31-86.
5. Bradley J.R. TNF-mediated inflammatory disease. J. Pathol. 2008, 214:149-160.
6. Casillas R.P., Kiser R.C., Truxall J.A., Singer A.W., Shumaker S.M., Niemuth N.A., Ricketts K.M., Mitcheltree L.W., Castrejon L.R., Blank J.A. Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model. J. Appl. Toxicol. 2000, 20(Suppl 1):S145-S151.
7. Chatterjee D., Mukherjee S., Smith M.G., Das S.K. Signal transduction events in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog. J. Biochem. Mol. Toxicol. 2003, 17:114-121.
8. Chen B., Tong Z., Ye Q., Nakamura S., Costabel U., Guzman J. Expression of tumour necrosis factor receptors by bronchoalveolar cells in hypersensitivity pneumonitis. Eur. Respir. J. 2005, 25:1039-1043.
9. Cho H.Y., Zhang L.Y., Kleeberger S.R. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-alpha receptors. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 280:L537-L546.
10. Cho H.Y., Morgan D.L., Bauer A.K., Kleeberger S.R. Signal transduction pathways of tumor necrosis factor-mediated lung injury induced by ozone in mice. Am. J. Respir. Crit. Care Med. 2007, 175:829-839.
11. Crosby L.M., Waters C.M. Epithelial repair mechanisms in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 298:L715-L731.
12. Dai H., Guzman J., Costabel U. Increased expression of apoptosis signalling receptors by alveolar macrophages in sarcoidosis. Eur. Respir. J. 1999, 13:1451-1454.
13. Dai H., Guzman J., Chen B., Costabel U. Production of soluble tumor necrosis factor receptors and tumor necrosis factor-alpha by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitis. Chest 2005, 127:251-256.
14. Debiak M., Kehe K., Burkle A. Role of poly(ADP-ribose) polymerase in sulfur mustard toxicity. Toxicology 2009, 263:20-25.
15. Ding M., Chen F., Shi X., Yucesoy B., Mossman B., Vallyathan V. Diseases caused by silica: mechanisms of injury and disease development. Int. Immunopharmacol. 2002, 2:173-182.
16. Emad A., Emad Y. Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation. J. Interferon Cytokine Res. 2007, 27:38-43.
17. Ermert M., Pantazis C., Duncker H.R., Grimminger F., Seeger W., Ermert L. In situ localization of TNFalpha/beta, TACE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue. Cytokine 2003, 22:89-100.
18. Fakhrzadeh L., Laskin J.D., Laskin D.L. Regulation of caveolin-1 expression, nitric oxide production and tissue injury by tumor necrosis factor-alpha following ozone inhalation. Toxicol. Appl. Pharmacol. 2008, 227:380-389.
19. Gaede K.I., Fitschen J., Ernst M., Martinet N., Schlaak M., Muller-Quernheim J. Expression of tumour necrosis factor receptors (CD120a and CD120b) on bronchoalveolar cells. Cytokine 1999, 11:611-616.
20. Ghanei M., Harandi A.A. Long term consequences from exposure to sulfur mustard: a review. Inhal. Toxicol. 2007, 19:451-456.
21. Ghanei M., Naderi M., Kosar A.M., Harandi A.A., Hopkinson N.S., Poursaleh Z. Long-term pulmonary complications of chemical warfare agent exposure in Iraqi Kurdish civilians. Inhal. Toxicol. 2010, 22:719-724.
22. Guignabert C., Taysse L., Calvet J.H., Planus E., Delamanche S., Galiacy S., d'Ortho M.P. Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L67-L74.
23. Hancock A., Armstrong L., Gama R., Millar A. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am. J. Respir. Cell Mol. Biol. 1998, 18:60-65.
24. Kehe K., Balszuweit F., Emmler J., Kreppel H., Jochum M., Thiermann H. Sulfur mustard research-strategies for the development of improved medical therapy. Eplasty 2008, 8:e32.
25. Kinnula V.L., Crapo J.D. Superoxide dismutases in the lung and human lung diseases. Am. J. Respir. Crit. Care Med. 2003, 167:1600-1619.
26. Korkmaz A., Kunak Z.I., Paredes S.D., Yaren H., Tan D.X., Reiter R.J. The use of melatonin to combat mustard toxicity. Neuro Endocrinol. Lett. 2008, 29:614-619.
27. Kumar O., Sugendran K., Vijayaraghavan R. Protective effect of various antioxidants on the toxicity of sulphur mustard administered to mice by inhalation or percutaneous routes. Chem. Biol. Interact. 2001, 134:1-12.
28. Laskin D.L., Sunil V.R., Laumbach R.J., Kipen H.M. Inflammatory cytokines and lung toxicity. Cytokines in human health: immunotoxicology, pathology and therapeutic applications 2007, 83-112. Humana Press Inc., Totowa, NJ. R. House, J. Descotes (Eds.).
29. Laskin D.L., Gardner G.R., Laskin J.D. Phagocytes. Comprehensive toxicology, immune system toxicology 2010, 133-153. Elsevier, UK. D. Lawrence (Ed.).
30. Laskin J.D., Black A.T., Jan Y.H., Sinko P.J., Heindel N.D., Sunil V., Heck D.E., Laskin D.L. Oxidants and antioxidants in sulfur mustard-induced injury. Ann. NY Acad. Sci. 2010, 1203:92-100.
31. Laskin J.D., Heck D.E., Laskin D.L. Nitric oxide pathways in toxic responses. General and applied toxicology 2010, 425-438. Wiley-Blackwell, UK. B. Ballantyne, T. Marrs, T. Syversen (Eds.).
32. Leme A.S., Berndt A., Williams L.K., Tsaih S.W., Szatkiewicz J.P., Verdugo R., Paigen B., Shapiro S.D. A survey of airway responsiveness in 36 inbred mouse strains facilitates gene mapping studies and identification of quantitative trait loci. Mol. Genet. Genomics 2010, 283:317-326.
33. Liu J.Y., Sime P.J., Wu T., Warshamana G.S., Pociask D., Tsai S.Y., Brody A.R. Transforming growth factor-beta(1) overexpression in tumor necrosis factor-alpha receptor knockout mice induces fibroproliferative lung disease. Am. J. Respir. Cell Mol. Biol. 2001, 25:3-7.
34. Malaviya R., Sunil V.R., Cervelli J., Anderson D.R., Holmes W.W., Conti M.L., Gordon R.E., Laskin J.D., Laskin D.L. Inflammatory effects of inhaled sulfur mustard in rat lung. Toxicol. Appl. Pharmacol. 2010, 248:89-99.
35. McClintock S.D., Till G.O., Smith M.G., Ward P.A. Protection from half-mustard-gas-induced acute lung injury in the rat. J. Appl. Toxicol. 2002, 22:257-262.
36. McClintock S.D., Hoesel L.M., Das S.K., Till G.O., Neff T., Kunkel R.G., Smith M.G., Ward P.A. Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J. Appl. Toxicol. 2006, 26:126-131.
37. Migliaccio C.T., Buford M.C., Jessop F., Holian A. The IL-4Ralpha pathway in macrophages and its potential role in silica-induced pulmonary fibrosis. J. Leukoc. Biol. 2008, 83:630-639.
38. Misson P., van den Brule S., Barbarin V., Lison D., Huaux F. Markers of macrophage differentiation in experimental silicosis. J. Leukoc. Biol. 2004, 76:926-932.
39. Mukherjee S., Stone W.L., Yang H., Smith M.G., Das S.K. Protection of half sulfur mustard gas-induced lung injury in guinea pigs by antioxidant liposomes. J. Biochem. Mol. Toxicol. 2009, 23:143-153.
40. Mukhopadhyay S., Hoidal J.R., Mukherjee T.K. Role of TNFalpha in pulmonary pathophysiology. Respir. Res. 2006, 7:125.
41. Murray L.A., Rosada R., Moreira A.P., Joshi A., Kramer M.S., Hesson D.P., Argentieri R.L., Mathai S., Gulati M., Herzog E.L., Hogaboam C.M. Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages. PLoS ONE 2010, 5:e9683.
42. Okuma T., Terasaki Y., Kaikita K., Kobayashi H., Kuziel W.A., Kawasuji M., Takeya M. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases. J. Pathol. 2004, 204:594-604.
43. O'Neill H.C., White C.W., Veress L.A., Hendry-Hofer T.B., Loader J.E., Min E., Huang J., Rancourt R.C., Day B.J. Treatment with the catalytic metalloporphyrin AEOL 10150 reduces inflammation and oxidative stress due to inhalation of the sulfur mustard analog 2-chloroethyl ethyl sulfide. Free Radic. Biol. Med. 2010, 48:1188-1196.
44. Ortiz L.A., Lasky J., Lungarella G., Cavarra E., Martorana P., Banks W.A., Peschon J.J., Schmidts H.L., Brody A.R., Friedman M. Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice. Am. J. Respir. Cell Mol. Biol. 1999, 20:825-833.
45. Ortiz L.A., Lasky J., Gozal E., Ruiz V., Lungarella G., Cavarra E., Brody A.R., Friedman M., Pardo A., Selman M. Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis. Am. J. Respir. Crit. Care Med. 2001, 163:244-252.
46. Papirmeister B., Feister A.J., Robinson S.I., Ford R.D. Medical defense against mustard gas: toxic mechanims and pharmacological implications 1991, CRC Press, Boca Raton, FL.
47. Park G.Y., Christman J.W. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L797-L805.
48. Ray R., Simbulan-Rosenthal C.M., Keyser B.M., Benton B., Anderson D., Holmes W., Trabosh V.A., Daher A., Rosenthal D.S. Sulfur mustard induces apoptosis in lung epithelial cells via a caspase amplification loop. Toxicology 2010, 271:94-99.
49. Rolin S., Masereel B., Dogne J.M. Prostanoids as pharmacological targets in COPD and asthma. Eur. J. Pharmacol. 2006, 533:89-100.
50. Shimabukuro D.W., Sawa T., Gropper M.A. Injury and repair in lung and airways. Crit. Care Med. 2003, 31:S524-S531.
51. Song H.M., Jang A.S., Ahn M.H., Takizawa H., Lee S.H., Kwon J.H., Lee Y.M., Rhim T.Y., Park C.S. Ym1 and Ym2 expression in a mouse model exposed to diesel exhaust particles. Environ. Toxicol. 2008, 23:110-116.
52. Sunil V.R., Patel K.J., Shen J.L., Reimer D., Gow A.J., Laskin J.D., Laskin D.L. Role of reactive nitrogen species in vesicant-induced lung injury and altered lung functioning. Toxicologist 2010, 114:A336.
53. Sunil V.R., Patel K.J., Shen J.L., Reimer D., Gow A.J., Laskin J.D., Laskin D.L. Functional and inflammatory alterations in the lung following exposure of rats to nitrogen mustard. Toxicol Appl Pharmacol 2011, 250:10-16.
54. Ucar M., Korkmaz A., Reiter R.J., Yaren H., Oter S., Kurt B., Topal T. Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol. Lett. 2007, 173:124-131.
55. van Helden H.P., Kuijpers W.C., Diemel R.V. Asthmalike symptoms following intratracheal exposure of Guinea pigs to sulfur mustard aerosol: therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal. Toxicol. 2004, 16:537-548.
56. Weinberger, B., Laskin, J.D., Sunil, V.R., Sinko, P.J., Heck, D.E., Laskin, D.L., in press. Sulfur mustard-induced pulmonary injury: Therapeutic approaches to mitigating toxicity. Pulmonary Pharmacology and Therapeutics. http://doi:10.1016/j.pupt.2010.09.004.
57. Wigenstam E., Rocksen D., Ekstrand-Hammarstrom B., Bucht A. Treatment with dexamethasone or liposome-encapsuled vitamin E provides beneficial effects after chemical-induced lung injury. Inhal. Toxicol. 2009, 21:958-964.
58. Wormser U., Langenbach R., Peddada S., Sintov A., Brodsky B., Nyska A. Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice. Toxicol. Appl. Pharmacol. 2004, 200:40-47.
59. Wynn T.A., Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin. Liver Dis. 2010, 30:245-257.
60. Yaren H., Mollaoglu H., Kurt B., Korkmaz A., Oter S., Topal T., Karayilanoglu T. Lung toxicity of nitrogen mustard may be mediated by nitric oxide and peroxynitrite in rats. Res. Vet. Sci. 2007, 83:116-122.
61. Zhang M., Qian J., Xing X., Kong F.M., Zhao L., Chen M., Lawrence T.S. Inhibition of the tumor necrosis factor-alpha pathway is radioprotective for the lung. Clin. Cancer Res. 2008, 14:1868-1876.
62. Zhang L., Wang M., Kang X., Boontheung P., Li N., Nel A.E., Loo J.A. Oxidative stress and asthma: proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluid. J. Proteome Res. 2009, 8:1631-1638.